author-photo

Farid El Hajbi

33

Papers

629

Citations

Citation Trend

Filter By

Papers (25) Sort By

Journal Conference Others

Nivolumab (NIVO) plus ipilimumab (IPI) or NIVO plus chemotherapy (chemo) versus chemo as first-line (1L) treatment for advanced esophageal squamous cell carcinoma (ESCC): First results of the CheckMate 648 study.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (11)
PRODIGE 59-DURIGAST trial: A randomised phase II study evaluating FOLFIRI + Durvalumab ± Tremelimumab in second-line of patients with advanced gastric cancer.

2021 Digestive and Liver Disease
Show All
- Source
- Cite
- Save
Citations (1)
FOLFIRINOX relative dose intensity and disease control in advanced pancreatic adenocarcinoma.

2021 Therapeutic Advances in Medical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial.

2021 Lancet Oncology
Show All
- Source
- Cite
- Save
Citations (40)
FOLFIRINOX de-escalation in advanced pancreatic cancer: a multicenter real-life study.

2020 Oncologist
Show All
- Source
- Cite
- Save
Citations (2)
261 Association of T-cell–inflamed gene expression profile and PD-L1 status with efficacy of pembrolizumab in patients with esophageal cancer from KEYNOTE-180

2020 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Atezolizumab plus modified docetaxel-cisplatin-5-fluorouracil (mDCF) regimen versus mDCF in patients with metastatic or unresectable locally advanced recurrent anal squamous cell carcinoma: a randomized, non-comparative phase II SCARCE GERCOR trial.

2020 BMC Cancer
Show All
- Source
- Cite
- Save
Citations (6)
Avelumab versus standard second line treatment chemotherapy in metastatic colorectal cancer patients with microsatellite instability: The SAMCO-PRODIGE 54 randomised phase II trial.

2020 Digestive and Liver Disease
Show All
- Source
- Cite
- Save
Citations (1)
Pooled analysis of 115 patients from updated data of Epitopes-HPV01 and Epitopes-HPV02 studies in first-line advanced anal squamous cell carcinoma:

2020 Therapeutic Advances in Medical Oncology
Show All
- Source
- Cite
- Save
Citations (5)
Anti-epidermal growth factor receptor therapy in combination with chemoradiotherapy for the treatment of locally advanced anal canal carcinoma: Results of a phase I dose-escalation study with panitumumab (FFCD 0904)

2019 Radiotherapy and Oncology
Show All
- Source
- Cite
- Save
Citations (5)